Surveillance of adverse events following immunization in the late 2010s: an overview of the importance, tools, and challenges

Immunization is one of the most effective measures to protect individuals and the population against vaccine-preventable diseases. Vaccines are safe and effective products, but like any other drug they can cause adverse events, which tend to become more visible as the diseases are controlled, elimin...

Descripción completa

Detalles Bibliográficos
Autores: Patrícia Mouta Nunes de Oliveira, Letícia Kegele Lignani, Deborah Araújo da Conceição, Paula Molinari Cardoso de Mello Farias, Paulo Roberto Gomes Takey, Maria de Lourdes de Sousa Maia, Luiz Antonio Bastos Camacho
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2020
País:Brasil
Institución:Fundação Oswaldo Cruz (FIOCRUZ)
Repositorio:Cadernos de Saúde Pública
Idioma:inglés
portugués
OAI Identifier:oai:ojs.teste-cadernos.ensp.fiocruz.br:article/7522
Acceso en línea:https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/7522
Access Level:acceso abierto
Palabra clave:Immunization
Immunization Programs
Postmarketing Product Surveillance
Imunização
Programas de Imunização
Vigilância de Produtos Comercializados
Descripción
Sumario:Immunization is one of the most effective measures to protect individuals and the population against vaccine-preventable diseases. Vaccines are safe and effective products, but like any other drug they can cause adverse events, which tend to become more visible as the diseases are controlled, eliminated, or eradicated. This study analyzed activities in the surveillance of adverse events following immunization (AEFI) based on data from the scientific literature, websites of immunization programs and health andregulatory agencies, and the authors’ expertise in the areas of immunizations and pharmacovigilance. With the increase in the number of vaccines in the basic immunization schedule and expansion of the population’s access, it has become essential to establish an efficient surveillance system for AEFI in Brazil. However, underreporting of cases in Brazil and in other countries hinders the detection of AEFI, especially rare events. Constantly updated information on vaccines’ risks and benefits allows immunization programs to provide rapid and clear responses to rumors of AEFI. This ensures the system’s reliability, especially in the face of the growing antivaccine movement and the increasing influence of social media in public opinion.